Multispectral Digital Colposcope With Probe for Detection of Cervical Intraepithelial Neoplasia
Status unconfirmed · Not applicable
Conditions studied: Carcinoma in Situ of Uterine Cervix, Cervical Intraepithelial Neoplasias, High Grade Cervical Intraepithelial Neoplasia
In brief
Although cervical cancer is a preventable cancer, every year more than one-quarter of a million women die worldwide from this disease. Internationally and nationally, cervical cancer is a disease that affects predominantly women who are poor and who live in resource poor settings. With the device the investigators are developing, known as the Multispectral Digital Colposcope with probe, our goal is to make detection of precancerous cervical lesions easier for the patient and for her provider. For the patient, our goal is to reduce the number of clinical visits needed to obtain a diagnosis and treatment and consequently to reduce the resulting fear and anxiety which usually accompanies an abnormal Pap smear. For the provider and the health care system, our goal is to obtain a more accurate diagnosis than the currently available diagnostic methods.
Key facts
- Study ID
- NCT02406352
- Run by
- Brookdale University Hospital Medical Center
- People needed
- 618
- Starts
- 2015-03-01
- Expected to finish
- 2017-12-01
- Last updated by the study team
- 2015-04-10
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Women who are at least 18 years old
- Are not pregnant (negative urine test) or breastfeeding
- Referred for colposcopy or LEEP treatment
- Can provide written informed consent
You may not qualify if…
- Women who do not meet the inclusion criteria
- Women who have had a hysterectomy
Where it is running
- Brookdale University Hospital and Medical Center — Brooklyn, New York, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.